Research News and Research

RSS

OHSU study reveals that fluoroquinolones may cause double vision

Highlights of September's Ophthalmology, the journal of the American Academy of Ophthalmology (Academy), include a 2009 review by the Academy of the safety and efficacy of a widely used corneal transplant procedure and a warning about an unusual but serious reaction to systemic fluroquinolones, a class of antibiotics used to treat a variety of bacterial infections.

1 Sep 2009

Mitoxantrone is highly efficient in suppressing multiple sclerosis

According to data supplied by the German Multiple Sclerosis Society's national MS register (DMSG - Deutsche Multiple Sklerose Gesellschaft), up to 10% of German MS patients have been treated with mitoxantrone in the past few years.

1 Sep 2009

Mistrust in health care system could impact patients' health and health care costs

Mistrust among patients, providers and insurers could harm patients' health and raise overall health care costs, reports a new study.

1 Sep 2009

Granulation tissue formed under gauze-based NPWT produces less scarring

At the 5th Joint Meeting of the European Tissue Repair Society and The Wound Healing Society in Limoges, France, Associate Professor Malin Malmsjo, MD, PhD of Lund University in Sweden presented never before seen ground-breaking research revealing that granulation tissue formed under gauze-based Negative Pressure Wound Therapy (NPWT) is more organized and contains fewer leukocytes than the granulation tissue formed under foam.

1 Sep 2009

Senior citizens in Nevada to be affected by the recent House bill

A new American Health Care Association analysis of the pending House health reform bill, combined with the impact of a recently-enacted Medicare regulation cutting Medicare-funded nursing home care by $12 billion over 10 years, finds seniors in Nevada requiring nursing and rehabilitative care will face total funding cuts of $186 million over that same time period. Nationally, the study finds, seniors' Medicare cuts will total $44 billion over 10 years, prompting Nevada’s long term care community to warn that seniors' care needs are endangered by the House bill, as are the jobs of almost 200 caregivers in Nevada alone.

31 Aug 2009

Cordis enrolls first patient in the CYPRESS clinical study

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.

31 Aug 2009

Family and friends play a significant role in breast cancer surgery decision

About three-quarters of women newly diagnosed with breast cancer have a friend or family member with them at their first visit with a surgeon. And that person plays a significant role in the patient's decision of what type of surgery to have, according to a new study from the University of Michigan Comprehensive Cancer Center.

31 Aug 2009

PrimeSuite provides physicians with access to lab results, radiology reports and transcribed documents from their community health system

Physicians using Greenway Medical Technologies’ electronic health record (EHR) solution, PrimeSuite, now have access to lab results, radiology reports and transcribed documents from their community health system through RelayHealth’s Virtual Information Exchange platform.

31 Aug 2009

MD Buyline introduces integrated capital planning and budgeting program

MD Buyline introduces Buyline BUDGET, an integrated capital planning and budgeting program for researching, selecting, budgeting, and purchasing capital equipment.

31 Aug 2009

MRRI research study to investigate how zolpidem might restore consciousness for patients in the vegetative state

Moss Rehabilitation Research Institute (MRRI), the research arm of MossRehab, one of the world’s leading clinical rehabilitation centers, has launched an ambitious research study to investigate how the sleep drug zolpidem might restore consciousness for patients in the vegetative state.

31 Aug 2009

New chief strategy officer for Merkle

Merkle (www.merkleinc.com), one of the nation’s largest and fastest growing database marketing agencies, announced the appointment of Vice President Pete Mehr, Ph.D., as chief strategy officer to its growing healthcare marketing practice, which launched earlier this year to provide data-driven marketing insight and strategy to leading healthcare and pharmaceutical clients.

31 Aug 2009

MabCure featured in the August edition of Biotechnology Focus magazine

MabCure, Inc. (“MabCure”), a biotechnology company using its proprietary technology to create highly specific monoclonal antibodies (MAbs) for the early detection of cancer, has been featured in the August edition of Biotechnology Focus, Canada's oldest and most successful magazine serving the Canadian life science industry.

31 Aug 2009

Fifth annual Pathology Visions conference to showcase digital pathology technology and its healthcare applications

The newly formed Digital Pathology Association (DPA), a non-profit organization committed to the advancement of digital pathology applications in healthcare, invites interested pathology professionals to join them for the fifth annual Pathology Visions conference, to be held September 13-15 in San Diego, CA, at the Marriott Hotel and Marina.

31 Aug 2009

Merck undergoes restructuring after Schering-Plough merger

Richard T. Clark, chairman, president and chief executive officer of Merck & Co., Inc. (NYSE: MRK) today announced a new organizational structure and named top management and senior leaders for the new Merck effective upon completion of the merger of Merck & Co., Inc. and Schering-Plough Corporation. Mr. Clark was named CEO of the combined company when the merger agreement was signed in March.

31 Aug 2009

Clinical trial results of Dabigatran proves its effectiveness for treating atrial fibrillation

Researchers today published promising results for a drug that could lead to a replacement for the very effective but difficult-to-use blood thinner Coumadin (sold generically as Warfarin), currently taken by millions of Americans to reduce their risk of stroke.

31 Aug 2009

Celladon announces completion of patient enrollment for Phase 2 CUPID clinical trial

Celladon Corporation and Momentum Research, Inc. today announced completion of enrollment of the phase 2 double-blind portion of the Calcium Up-regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) trial. Momentum Research is Celladon’s consulting and management organization with clinical expertise in the development of cardiovascular products and trials.

31 Aug 2009

New director appointed at the Saint John’s Neuroscience Institute

Saint John’s Health Center today announced the appointment of world-renowned neurosurgeon Amin Kassam, MD, as Director of the new Saint John’s Neuroscience Institute and faculty member of the John Wayne Cancer Institute at Saint John’s. Dr. Kassam will lead the development of the new Neuroscience Institute which will offer an international minimally invasive neurosurgery center, as well as neuro-oncology, neuro-vascular surgery and other neuroscience services.

31 Aug 2009

Psychogenics and Astrazeneca sign agreement to identify new compounds for treating Central Nervous System disorders

PsychoGenics Inc. and AstraZeneca have entered into a drug discovery and development agreement to identify compounds that are likely to be useful for the treatment of certain Central Nervous System (CNS) disorders.

31 Aug 2009

Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program

Peregrine Pharmaceuticals, Inc., today announced that noted cancer researcher Bruce Chabner, M.D., will serve as a clinical advisor to the company on the design of clinical trials for the bavituximab cancer program.

31 Aug 2009

Holistic health expert highlights the benefits of regular meditatation

Medical costs this year are hitting almost everyone in the pocketbook. With politicians scrambling to come up with a workable solution, Americans face dark days ahead as monthly insurance fees go up again, often with double-digit rate hikes. Is there any hope for hard-working Americans who face the challenge of paying these exorbitant fees?

31 Aug 2009

Research News and Research

OHSU study reveals that fluoroquinolones may cause double vision

Mitoxantrone is highly efficient in suppressing multiple sclerosis

Mistrust in health care system could impact patients' health and health care costs

Granulation tissue formed under gauze-based NPWT produces less scarring

Senior citizens in Nevada to be affected by the recent House bill

Cordis enrolls first patient in the CYPRESS clinical study

Family and friends play a significant role in breast cancer surgery decision

PrimeSuite provides physicians with access to lab results, radiology reports and transcribed documents from their community health system

MD Buyline introduces integrated capital planning and budgeting program

MRRI research study to investigate how zolpidem might restore consciousness for patients in the vegetative state

New chief strategy officer for Merkle

MabCure featured in the August edition of Biotechnology Focus magazine

Fifth annual Pathology Visions conference to showcase digital pathology technology and its healthcare applications

Merck undergoes restructuring after Schering-Plough merger

Clinical trial results of Dabigatran proves its effectiveness for treating atrial fibrillation

Celladon announces completion of patient enrollment for Phase 2 CUPID clinical trial

New director appointed at the Saint John’s Neuroscience Institute

Psychogenics and Astrazeneca sign agreement to identify new compounds for treating Central Nervous System disorders

Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program

Holistic health expert highlights the benefits of regular meditatation

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest Life Science News